Finch Therapeutics Group, Inc.
FNCH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,145 | $5,792 | $22,892 | $473,696 |
| - Cash | $10,262 | $25,124 | $71,038 | $133,481 |
| + Debt | $27,791 | $30,126 | $52,339 | $6,015 |
| Enterprise Value | $35,674 | $10,794 | $4,193 | $346,230 |
| Revenue | $0 | $107 | $861 | $18,532 |
| % Growth | -100% | -87.6% | -95.4% | – |
| Gross Profit | -$174 | -$1,413 | -$4,646 | -$38,747 |
| % Margin | – | -1,320.6% | -539.6% | -209.1% |
| EBITDA | -$13,703 | -$32,482 | -$82,687 | -$57,684 |
| % Margin | – | -30,357% | -9,603.6% | -311.3% |
| Net Income | -$13,877 | -$74,754 | -$114,646 | -$58,160 |
| % Margin | – | -69,863.6% | -13,315.4% | -313.8% |
| EPS Diluted | -8.64 | -46.59 | -72.12 | -36.72 |
| % Growth | 81.5% | 35.4% | -96.4% | – |
| Operating Cash Flow | – | -$31,505 | -$74,851 | -$67,133 |
| Capital Expenditures | – | $0 | -$2,182 | -$15,983 |
| Free Cash Flow | – | -$31,505 | -$77,033 | -$83,116 |